RAPIDHealth Clinical Track — IP Filing in Preparation — Integrated Multi-Tissue Reconstruction
RAPID
SYSTEM.
Skin. Bone. Nerve. Simultaneously. One operation.
The Problem
COMPLEX WOUNDS
REQUIRE THREE OPERATIONS.
A blast injury that destroys skin, fractures bone, and severs peripheral nerves currently requires staged reconstruction — typically three separate surgical procedures, each with its own healing interval, its own recovery pathway, and its own risk of failure at the interface between tissue types.
The problem is not that the individual scaffolds don't work — RAPIDSkin, RAPIDBone, and RAPIDNeural each address their target tissue in isolation. The problem is the interface. Skin laid over bone that cannot integrate with nerve creates a reconstruction that looks complete but functions poorly. Staged procedures extend treatment timelines, increase infection risk, and put the patient through multiple anaesthetic events.
RAPIDSystem Architecture
THREE LAYERS.
ONE OPERATION.
RAPIDSystem integrates three proven scaffold technologies from the same supply chain. Same feedstock. Same processing protocol. Same holobiont compound profile. Designed to be placed simultaneously in a single surgical procedure.
RAPIDSkin
GB2607398.1 — Lyophilised dermal regeneration scaffoldThe outer layer. Lyophilised holobiont-intact sargassum scaffold. No growth factors added — the living organism provides endogenous FGF-2, TGF-β, and EGF analogues directly. No cold chain. Dermal fibroblast infiltration and keratinocyte migration initiated from day one. In RAPIDSystem, the dermal scaffold is positioned to interface directly with the bone scaffold at the wound margin — sharing the same holobiont biological profile ensures chemical compatibility rather than immune conflict.
RAPIDBone
GB2607402.1 — Nano-HA composite osseous scaffoldThe structural layer. Nano-hydroxyapatite composite incorporating holobiont-intact sargassum-derived fucoidan. Intrinsic osteoinduction without recombinant BMP — native fucoidan drives Runx2/Sp7 osteogenic differentiation directly. CT-derived geometry enables patient-specific scaffold fabrication. In the RAPIDSystem context, RAPIDBone provides the structural anchor around which nerve conduit and dermal scaffold are positioned — load-bearing architecture that also delivers anti-inflammatory and antimicrobial protection from the shared holobiont compound profile.
RAPIDNeural
GB2607492.2 — Peripheral nerve repair and remyelination platformThe functional layer. Nerve conduit incorporating native-sulphation fucoidan for NGF surface presentation via sulphate ester groups. 30mm+ nerve gap capability — beyond the current 26mm clinical ceiling that forces autograft. PI3K/AKT/mTOR remyelination pathway activation. In the RAPIDSystem assembly, the neural conduit routes through and alongside the bone scaffold, with the dermal layer closing over the complete reconstruction. The shared biological environment — same holobiont, same fucoidan sulphation profile — provides consistent signalling across the tissue interface.
The Integration Advantage
SAME FEEDSTOCK. SAME PROCESSING CHAIN. SAME BIOLOGICAL ENVIRONMENT ACROSS ALL THREE TISSUE INTERFACES.
The reason RAPIDSystem is possible — and why no competitor can replicate it — is that all three scaffolds are derived from the same organism, processed by the same non-thermal protocol, with the same holobiont compound profile intact. There is no immune conflict at the interface because there is no biological mismatch. The tissues are receiving the same biological signals from the same source.
Development Status
IP FILING
IN PREPARATION.
RAPIDSystem builds on three separate patent applications already filed. The integration architecture — the specific method of simultaneous multi-tissue scaffold placement from a single supply chain — is the subject of the pending RAPIDSystem patent application.
Pre-commercial. Seeking clinical collaboration partners with complex wound reconstruction, orthopaedic oncology, or blast injury expertise. Full technical data available under NDA.